Bicycle Therapeutics plc (BCYC) presents a materially negative equity recovery posture under liquidation analysis as of March 31, 2026, despite a positive book stockholders' equity of $554.3M. The dominant asset is cash and cash equivalents of $559.5M, which recovers at par under the liquidation lens. Total assets of $652.4M include $619.1M current assets (principally cash), $5.7M net PP&E, $14.5M operating lease ROU assets, and $12.9M other noncurrent assets. Applying standard haircuts: cash/restricted cash ~$560M at 100%; prepaid and other current assets of $18.7M at roughly 50% recovery (~$9M); PP&E at 50% (~$2.9M); ROU assets carry no independent liquidation value; intangibles and R&D pipeline value at zero. Gross liquidated asset value approximates $572M. Total liabilities at face value are $98.1M, including $48.9M current liabilities (accrued liabilities $40.1M, accounts payable $6.0M, employee-related liabilities $9.1M, deferred revenue current $2.8M) and $49.2M noncurrent liabilities (operating lease noncurrent $13.9M, deferred revenue noncurrent $34.3M). Deferred revenue of $37.1M total would not extinguish on wind-up without corresponding service delivery and could remain a claim on the estate. Operating lease obligations total $15.1M on-balance-sheet at ASC 842 carrying value; the undiscounted future minimum commitments are $17.9M through maturity. Finance lease liability is de minimis at $0.8M. Off-balance-sheet purchase commitments of $5.2M (unrecorded unconditional purchase obligations per XBRL tag) add additional wind-up exposure. Net liquidation recovery to equity is positive but thin relative to book equity, approximately $474M-$480M after conservative haircuts — consistent with MFFAIS CLV/LLV of $496M. The period reflects the first quarter post the strategic reprioritization announced March 2026 (30% workforce reduction, 50% expected operating cost reduction). Q1 2026 operating cash burn was $65.9M on revenues of only $0.9M (collaboration), implying a cash runway of roughly 8-9 quarters at current burn before reserves are exhausted, though the company projects reduced burn from the restructuring. Q1 2026 net loss was $60.8M. The accumulated deficit stands at $960.6M. The company has no debt other than lease obligations and the deferred revenue liability stack. The accumulated deficit increased from the prior annual period (10-K as of December 31, 2025, which showed a full-year net loss of $219.0M) — the Q1 2026 loss adds $60.8M to that trajectory. The most significant change quarter-over-quarter is the reduction in cash by $68.6M (from approximately $628M at year-end 2025 implied by the period-decrease tag), partially offset by the expectation of structurally lower operating costs from the workforce reduction. Filing discusses the August 2025 workforce reduction ($5.3M severance) and the March 2026 workforce reduction (~$7.2M expected severance) in MD&A but neither restructuring charge is separately tagged in XBRL as a restructuring liability on the balance sheet as of March 31, 2026.
▼ Community Notes